Contents of the Financial Statements

for the Period Ended 31 December 2024

Directors' report period ended 31 December 2024

The directors present their report with the financial statements of the company for the period ended 31 December 2024

Directors

The director shown below has held office during the whole of the period from
1 January 2024 to 31 December 2024

The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006

This report was approved by the board of directors on
26 September 2025

And signed on behalf of the board by:
Name: Sarah Curtis
Status: Director

Profit And Loss Account

for the Period Ended 31 December 2024

Balance sheet

As at 31 December 2024

The notes form part of these financial statements

Balance sheet statements

For the year ending 31 December 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The notes form part of these financial statements

Notes to the Financial Statements

for the Period Ended 31 December 2024

• 1. Accounting policies

  Basis of measurement and preparation

  These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

  Other accounting policies

  Basis of preparation These financial statements are prepared on going concern basis under the historical cost convention, and in accordance with the Companies Act 2006 and applicable accounting standards in the United Kingdom. The principal accounting policies, which have been applied consistently to all the years presented, unless otherwise indicated, are set out below. The preparation of financial statements in conformity with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise its judgement in the process of applying the Company’s accounting policies. The areas involving a higher degree of judgement or complexity, or areas where assumptions and estimates are significant to the financial statements are disclosed in note 4. The financial statements have been presented in Euros which is the functional currency of the Company. The level of rounding is to the nearest Euro , unless otherwise stated Going concern The parent company, Journey Personal Care Holdings Ltd, has confirmed that it will continue to provide financial support to the Company for the foreseeable future and for at least twelve months from the date of approval of these financial statements. Accordingly, the financial statements have been prepared on the going concern basis. Journey Personal Care Holdings Ltd’s group cash flow forecast and projections, taking account of reasonably foreseeable changes in external factors and trading performance, show that the group should be able to operate within the level of its current facility and will be able to comply with future financial covenant obligations. Exemptions for qualifying entities The Company has taken advantage of the following disclosure exemption in preparing these financial statements, as permitted by the FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland. the requirements of Section 4 Statement of Financial Position paragraph 4.12 (a)(iv) the requirements of Section 7 Statement of Cash Flows the requirements of Section 3 Financial Statement Presentation paragraph 3.17(d) the requirements of Section 11 Financial Instruments paragraph 11.39 to 11.48 A the requirements of Section 12 Other Financial Instruments paragraphs 12.26 to 12.29 the requirements of Section 33 Related Party Disclosures paragraph 33.7 the requirement to disclose effect of international tax reform-Pillar two model rules as required by paragraph 29.28(b), 29.29 of FRS 102. The information is included in the consolidated financial statements of the parent company, AIPCF VII DPC Funding LP are available from the Companies House and from the Company at Maples Corporate Services Limited, P.O. Box 309, Ugland House, South Church Street, George Town, Grand Cayman KYI-1104, Cayman Islands. Foreign currencies The Company’s functional and presentational currency is the Euro. Transactions in foreign currencies are recorded at the rate ruling at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are retranslated at the rate of exchange ruling at the balance sheet date. All differences are taken to the Profit and Loss Account Creditors Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method Taxation A current tax liability is recognised for the tax payable on the taxable profit of the current and part periods. A current tax asset is recognised in the respect of a tax loss that can be carried back to recover tax paid in previous period. Deferred tax is recognised in respect of all timing difference between the recognition of income and expenses in the financial statements and their inclusion in tax assessment. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against reversal of deferred tax liabilities of other future taxable profits. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply reversal of the timing difference. Current and deferred tax liabilities are not discounted. Financial instruments The Company has applied the Section 11 and 12 of FRS 102 in respect of financial instruments. The Company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities like trade and other accounts receivable and payable, loans from banks and other third parties, loans to related parties and investments in non-puttable ordinary shares. Debt instruments (other than those wholly repayable or receivable within one year), including loans and other accounts receivable and payable, are initially measured at the present value of the future cash flows and subsequently at amortised cost using the effective interest method. Debt instruments that are payable or receivable within one year, typically trade payables or receivables, are measured, initially and subsequently, at the undiscounted amount of the cash or other consideration expected to be paid or received. However, if the arrangements of a short-term instrument constitute a financing transaction, like payment of a trade debt deferred beyond normal business terms or finance at a rate of interest that is not market rate or in case of an outright short term loan not at market rate, the financial asset or liability is measured, initially, at the present value of the future cash flow discounted at a market rate of interest for a similar debt instrument and subsequently at amortised cost. Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If the objective evidence of impairment is found, an impairment loss is recognised in the Profit and Loss Account. For financial assets measured at amortised cost, the impairment loss is measured as the difference between an asset’s carrying amount and the present value of estimated cash flows discounted at the asset's original effective interest rate. If a financial asset has a variable interest rate, the discount rate for measuring any impairment loss is the current effective interest rate determined under the contract. For financial assets measured at cost less impairment, the impairment loss is measured as the difference between an asset’s carrying amount and best estimate of recoverable amount, which is an approximation of the amount that the Company would receive for the asset if it were to be sold at the balance sheet date. Financial assets and liabilities are offset and the net amount reported in the balance sheet when there is an enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or realise the assets and settle the liability simultaneously. Share capital Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of new ordinary shares or options are shown in equity as deduction, net of tax, from proceeds Derivatives The currency swap is within the Group (vs the Swedish entity Attends Healthcare AB). It is a debt and a receivable (net debt) in different currencies (USD and SEK). The value fluctuates with changes in the exchange rates. Any changes in value are recognized in the Profit and Loss Account. The debt is translated to the current exchange rate in the reporting currency at accounting close date from the European Central Bank.

Notes to the Financial Statements

for the Period Ended 31 December 2024

• 2. Employees

  	2024	2023
  Average number of employees during the period	0	0